Amalio Ordóñez, MD

Articles by Amalio Ordóñez, MD

The UFT/Leucovorin/Etoposide Regimen for the Treatment of Advanced Gastric Cancer

ByManuel González Barón, MD,Enrique Espinosa, MD,Jaime Feliu, MD,Amalio Ordóñez, MD,Pilar Zamora, MD,Javier De Castro, MD,Carlos García Girón, MD,Pilar García Alfonso, MD,Pilar Garrido, MD,Joaquin Belón, MD,Maria Lomas, MD

September 2nd 1997

Gastric cancer is the most chemosensitive adenocarcinoma among digestive neoplasms. A few years ago, we performed a phase II trial with the FLEP regimen, in which fluorouracil (5-FU) and leucovorin are combined

Latest Updated Articles

The UFT/Leucovorin/Etoposide Regimen for the Treatment of Advanced Gastric Cancer
Published: September 2nd 1997 | Updated:

Amalio Ordóñez, MD

Articles by Amalio Ordóñez, MD

The UFT/Leucovorin/Etoposide Regimen for the Treatment of Advanced Gastric Cancer

Latest Updated Articles

Trending on CancerNetwork

ADCE-D01 Earns FDA Fast Track Designation in Soft Tissue Sarcoma

Serplulimab Plus Chemo Meets EFS End Point in Early-Stage Gastric Cancer

KRd Appears to Exhibit Greater Outcomes in Standard-Risk Multiple Myeloma

The Show and After Show Previews the 2025 ESMO Annual Congress

KRd-Based Quadruplets May “Eliminate” Transplant Need for Multiple Myeloma